- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI SWOT - About
Centene Corp (CNC)

- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- 1Y
- 1M
- 1W
Upturn Advisory Summary
11/03/2025: CNC (1-star) is currently NOT-A-BUY. Pass it for now.
1 Year Target Price $39.29
1 Year Target Price $39.29
| 7 | Strong Buy |
| 3 | Buy |
| 9 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -19.5% | Avg. Invested days 36 | Today’s Advisory PASS |
Upturn Star Rating ![]() | Upturn Advisory Performance | Stock Returns Performance |
Key Highlights
Company Size Large-Cap Stock | Market Capitalization 16.96B USD | Price to earnings Ratio - | 1Y Target Price 39.29 |
Price to earnings Ratio - | 1Y Target Price 39.29 | ||
Volume (30-day avg) 19 | Beta 0.48 | 52 Weeks Range 25.08 - 66.81 | Updated Date 11/3/2025 |
52 Weeks Range 25.08 - 66.81 | Updated Date 11/3/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -10.67 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Earnings Date
Report Date 2025-10-29 | When Before Market | Estimate -0.18 | Actual 0.5 |
Profitability
Profit Margin -3.16% | Operating Margin (TTM) 0.55% |
Management Effectiveness
Return on Assets (TTM) 2.01% | Return on Equity (TTM) -21.86% |
Valuation
Trailing PE - | Forward PE 10.37 | Enterprise Value 18379517060 | Price to Sales(TTM) 0.1 |
Enterprise Value 18379517060 | Price to Sales(TTM) 0.1 | ||
Enterprise Value to Revenue 0.1 | Enterprise Value to EBITDA 3.91 | Shares Outstanding 491518000 | Shares Floating 462764197 |
Shares Outstanding 491518000 | Shares Floating 462764197 | ||
Percent Insiders 0.46 | Percent Institutions 98.73 |
Upturn AI SWOT
Centene Corp

Company Overview
History and Background
Centene Corporation was founded in 1984 as a managed care organization. Originally focusing on government-sponsored healthcare programs, it has grown to become a major player in the Medicaid, Medicare, and Health Insurance Marketplace spaces. Significant milestones include acquisitions and expansions into new markets and lines of business.
Core Business Areas
- Managed Care: Provides managed healthcare services primarily through Medicaid, Medicare, and Marketplace plans. Offers comprehensive healthcare coverage, including medical, behavioral, and pharmacy benefits.
- Specialty Services: Offers specialty healthcare services such as behavioral health, vision, dental, and pharmacy benefit management (PBM) through Envolve Pharmacy Solutions.
- International: Operating in some global healthcare markets like Europe offering various healthcare services
Leadership and Structure
The leadership team consists of the CEO, CFO, and other key executives. The organizational structure is hierarchical with divisions focused on managed care operations, specialty services, and corporate functions.
Top Products and Market Share
Key Offerings
- Medicaid Managed Care: Provides healthcare coverage to low-income individuals and families through state Medicaid programs. Centene is a major player in this market. Competitors: UnitedHealth Group (UNH), Molina Healthcare (MOH), Humana (HUM). In 2023, Medicaid represented approximately 63% of Centene's total health plan premium revenue. Medicaid managed care market share estimated around 14%.
- Medicare Advantage: Offers Medicare Advantage plans to seniors and other eligible individuals. Competitors: UnitedHealth Group (UNH), Humana (HUM), CVS Health (CVS). Market share is growing, although smaller compared to other established players. Centene's Medicare revenue accounts for 25% of total health plan premium revenue.
- Health Insurance Marketplace: Offers health insurance plans through the Affordable Care Act (ACA) marketplace. Competitors: UnitedHealth Group (UNH), Cigna (CI), Kaiser Permanente. Rapidly growing segment within Centene's business, accounting for 12% of total health plan premium revenue.
Market Dynamics
Industry Overview
The managed care industry is experiencing growth driven by increasing government spending on healthcare, aging population, and expansion of Medicaid and Medicare programs. Consolidation is also a key trend.
Positioning
Centene is a leading managed care provider focused on government-sponsored healthcare programs. It has a strong presence in the Medicaid market and is expanding its Medicare and Marketplace businesses. Competitive advantages include its expertise in managing complex populations and its scale.
Total Addressable Market (TAM)
The total addressable market for managed care is substantial, estimated to be in the trillions of dollars. Centene is well-positioned to capture a significant portion of this market, especially within the government-sponsored healthcare segment. The Medicaid TAM is estimated to be at $689 billion in 2023. The Medicare Advantage TAM is expected to grow to $590 billion by 2027. ACA Marketplace estimated at over $200 billion annually.
Upturn SWOT Analysis
Strengths
- Strong presence in Medicaid market
- Expertise in managing complex populations
- Scale and geographic diversification
- Focus on government-sponsored healthcare programs
- Growing Medicare Advantage business
Weaknesses
- High reliance on government funding
- Exposure to regulatory changes
- Relatively lower margins compared to commercial insurance
- Integration challenges from acquisitions
- Debt burden
Opportunities
- Expansion into new markets and geographies
- Growth in Medicare Advantage enrollment
- Increasing demand for value-based care
- Strategic acquisitions and partnerships
- Growth in Health Insurance Marketplace
Threats
- Changes in government healthcare policy
- Increased competition from other managed care providers
- Rising healthcare costs
- Economic downturn affecting Medicaid enrollment
- Cybersecurity threats
Competitors and Market Share
Key Competitors
- UNH
- HUM
- MOH
- CVS
Competitive Landscape
Centene's advantages include its focus on government-sponsored healthcare and its expertise in managing complex populations. Disadvantages include its reliance on government funding and its relatively lower margins compared to some competitors. Centene is focusing on growing their medicare and marketplace portfolio to be more competitive.
Major Acquisitions
WellCare Health Plans
- Year: 2020
- Acquisition Price (USD millions): 17300
- Strategic Rationale: Expanded Centene's Medicaid and Medicare Advantage businesses and increased its scale and geographic reach.
Growth Trajectory and Initiatives
Historical Growth: Centene has experienced strong growth over the past decade, driven by organic growth, acquisitions, and expansion into new markets.
Future Projections: Analyst estimates project continued revenue growth, driven by increasing enrollment in Medicaid, Medicare Advantage, and Marketplace plans. Profitability is expected to improve as Centene manages medical costs and achieves greater efficiency. Analysts predict annual revenue growth of 5-8% over the next 3-5 years.
Recent Initiatives: Recent strategic initiatives include acquisitions to expand its presence in new markets, investments in technology to improve care management, and efforts to reduce administrative costs.
Summary
Centene is a significant player in the managed care industry, particularly within government-sponsored healthcare programs. Its strengths lie in its Medicaid expertise and large scale. While facing challenges such as regulatory risks and margin pressures, Centene is positioned for continued growth through market expansion and strategic initiatives. Investors must watch how it handles its large debt and focus on expansion beyond Medicaid.
Similar Stocks
Sources and Disclaimers
Data Sources:
- Company Filings (SEC)
- Industry Reports
- Analyst Estimates
- Company Website
Disclaimers:
The data and analysis provided are for informational purposes only and should not be considered financial advice. Market data and analyst estimates are subject to change.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Centene Corp
Exchange NYSE | Headquaters Saint Louis, MO, United States | ||
IPO Launch date 2001-12-13 | CEO & Director Ms. Sarah M. London | ||
Sector Healthcare | Industry Healthcare Plans | Full time employees 60500 | Website https://www.centene.com |
Full time employees 60500 | Website https://www.centene.com | ||
Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, and commercial organizations in the United States. The company operates through four segments: Medicaid, Medicare, Commercial, and Other. The Medicaid segment offers the temporary assistance for needy families; medicaid expansion; aged, blind, or disabled; and children's health insurance programs, as well as long-term services and supports; foster care; and medicare-medicaid plans. This segment also provides healthcare products and services. The Medicare segment offers special needs and medicare supplement, and prescription drug plans. The Commercial segment provides health insurance marketplace product for individual, small, and large group commercials. The Other segment operates clinical healthcare and pharmacies, as well as offers vision and dental, behavioral health, federal, and corporate management services. It provides services through primary and specialty care physicians, hospitals, behavioral health practitioners, and ancillary providers. The company was founded in 1984 and is headquartered in Saint Louis, Missouri.

Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.
Home 

